Medical Oncology Trials

Breast Cancer, Ovarian Cancer, Gynaecological Cancers, Kidney Cancer, Bladder Cancer, Prostate Cancer, Solid Tumours

The Medical Oncology Clinical Research team, based within the Mater Cancer Care Centre, currently has 22 actively recruiting trials. The trials are across a range of solid cancers, with a special focus on women’s and urological cancers.

The trials are examining new forms of treatment other than chemotherapy, targeted therapies that aim to reduce side effects and new combinations of treatments with an aim to address many of the unanswered questions in treating cancer.

The clinical trial within Medical Oncology research are overseen by four highly experienced female medical oncologist who are passionate about finding the most appropriate form of treatment for each patient they care for. There is a team of clinical researchers who all have a background in oncology nursing and are able to provide holistic care to patients and families who are involved in clinical trials.

All care is delivered within the MCCC which allows patients and their families to access the many supportive services available to patients at Mater during their cancer journey.

Category
Trial Status
Recruiting
Trial Phase
Phase 0
Trial contact details
Contact Person
Caitlin Bennett
What you need to know

Who can take part?

Patients with a cancer diagnosis should seek referral from their physician to Mater Cancer Centre, where our Oncologist will assess eligibility for our active clinical trials.

What is involved for you?

Requirements for participants vary from study to study.

All research clinical trials news

2023 was an outstanding year for Mater Research with $13.7 million in grant funding received and 424 publications recorded.

29

Feb

Highlighting Mater Research’s year of achievements: 2023 Annual Report

When Monique Perry was diagnosed with aggressive triple-negative breast cancer she feared her family history was about to repeat itself.

27

Oct

Clinical trials give Queensland breast cancer patients hope

Mater researchers in Brisbane are leading a trial of a game-changing flu vaccine that has the potential to provide greater and more durable protection against the virus.

23

May

Mater launches trial of Australian-first flu vaccine

Displaying results 1-3 (of 18)
 |<  < 1 - 2 - 3 - 4 - 5 - 6  >  >|